Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Receivables (2022 - 2025)

Historic Receivables for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to $550000.0.

  • Lucid Diagnostics' Receivables rose 131025.64% to $550000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $550000.0, marking a year-over-year increase of 131025.64%. This contributed to the annual value of $45000.0 for FY2024, which is 0.0% changed from last year.
  • Latest data reveals that Lucid Diagnostics reported Receivables of $550000.0 as of Q3 2025, which was up 131025.64% from $373000.0 recorded in Q2 2025.
  • Lucid Diagnostics' Receivables' 5-year high stood at $10.7 million during Q2 2023, with a 5-year trough of $21000.0 in Q3 2023.
  • For the 4-year period, Lucid Diagnostics' Receivables averaged around $2.4 million, with its median value being $266500.0 (2024).
  • Per our database at Business Quant, Lucid Diagnostics' Receivables plummeted by 9968.38% in 2023 and then skyrocketed by 131025.64% in 2025.
  • Quarter analysis of 4 years shows Lucid Diagnostics' Receivables stood at $5.0 million in 2022, then plummeted by 99.1% to $45000.0 in 2023, then changed by 0.0% to $45000.0 in 2024, then soared by 1122.22% to $550000.0 in 2025.
  • Its last three reported values are $550000.0 in Q3 2025, $373000.0 for Q2 2025, and $61000.0 during Q1 2025.